🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Here again is the remarkable impact of immunotherapy for intractable cancer via engineered T cells gift link nytimes.com/2025/06/03/hea…

Unfortunately, the Irish government's approach to cancer is passive. We have a massive budget surplus but can't afford life-saving cancer medicines for patients. UCAN IRELAND

Another cancer treatment denied to Irish cancer patients. This time, it's CAR T to treat Myeloma blood cancer. UCAN IRELAND

The European Commission has approved a fixed-duration Bruton’s tyrosine kinase (BTK) selective inhibitor, Calquence (acalabrutinib) plus venetoclax, with or without obinutuzumab, to treat adults with previously untreated chronic lymphocytic leukaemia pharmaceutical-technology.com/news/ec-astraz…

Although Department of Health has not yet published the recommendations of the DoH Mazars Implementation group (as promised by the previous Minister for Health), I am reliably informed that 34 new staff have been employed by the NCPE (no longer on x) based on this groups

Have you or anyone you know been affected by #ovariancancer ? Then help us to raise awareness & meet like-minded people by joining Target Ovarian Cancer Ovar-Dressed walk at Stormont Sunday 29th June. Still time to sign up 🩵 #womenshealth #Belfast 👇👇 targetovariancancer.org.uk

The NTPF is a good idea, in principle, to allow public patients to access the readily available capacity in private hospitals. The politicians who established the NTPF must have recognised that there was a capacity problem in the HSE Yet, still today, somehow, there seems to

Our drug approval system is broken and government inaction is failing our cancer community, but we are also failing to support the clinical community left on the front line unable to treat cancer patients with the best treatments. UCAN IRELAND

We are very proud of our UCAN member Christine Campbell powerful advocacy at Northern Ireland Assembly Health Committee Inquiry: Access to Palliative Care Services 👏❤️ #PowerfulPatientVoices #PalliativeCareNeeds #UnitedCancerVoicesIE

Proud to see and hear the strong Irish participation at #EHA25. Ruth Clifford at the panel discussion on leveraging efficacy in this new fixed duration era of #CLL Also great to see our clinical nurse specialists Fidelma Hackett Ger Walpole and Mary Kelly Jan Rynne

➡️➡️Big CLL news! Munir et al OS and PFS adv for MRD driven I&V over ibrutinib in 1L #CLL #EHA2025 Congrats to all FLAIR trial 🇬🇧group Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…

Health-economists are clear that new cancer treatments do not represent value for money. I agree the treatments cost too much. Cancer treating clinicians are clear that these treatments work well enough that they would like to be able to prescribe them. The HSE response to

More from the Flair trial results at #EHA2025 Ibrutinib plus venetoclax significantly improved responses, progression free survival and overall survival in CLL.

Presented at #EHA2025: Among patients with CLL undetectable MRD and progression-free survival were more common with ibrutinib–venetoclax than with ibrutinib alone or chemoimmunotherapy, with benefits sustained at 5 years. Full FLAIR phase 3 trial nej.md/3SMNdC4

At UCAN IRELAND it's our mission to highlight inequalities in access to cancer treatments & fight for patients. This is why. This is the reality experienced by patients & their families. It's heartbreaking 💔 #UnitedCancerVoicesIE #AccessToCancerTherapies #CancerKnowsNoBorders

FLAIR phase 3 trial results: nej.md/3SMNdC4  !! Amazing results with an unprecedented 5 year PFS > 90% for I + V in a RCT for CLL 1L

Michael Rynne Are we ready to adopt MRD guided schedule ? Amazing results

Lymphoma patients need timely access to treatments. This family live one hour from a CAR T centre in Dublin but had to travel to London. Do our governments discuss cross border access? Jennifer Carroll MacNeill TD Wes Streeting Sorcha Eastwood MP Lymphoma Coalition bbc.com/news/articles/…

Improving Cancer Outcomes with Better Lynch Syndrome Testing: A Cost-Benefit Study lynchsyndromeireland.com/2025/06/18/imp… via @lynchsyndromirl

Few understand the challenges faced more than those experiencing them. Great patient-led #research survey on impact of #ProstateCancer treatment on sexual & mental health still open & looking for contributions from patient & partners. Please share 🙏 cancertrials.ie/proact-survey/